👉 Check out From Insight to Action: Integrating Cell-Free DNA Testing into Daily Transplant Care by #Natera, which is now available on-demand. Leading voices in #transplantation have a dynamic discussion on #cfDNA technology.💡📽️ Watch now at 🔗 bit.ly/4bYH7aU
Minetta Liu, MD, chief medical officer for Natera oncology, recently participated in discussions about the importance of molecular residual disease testing and the role of circulating tumor DNA. Learn more about Signatera™ during an upcoming webinar: https://ow.ly/z4fA50Yvrhv
#PMWC26 #Natera #ctDNA
Join Gerald Feldman, MD, PhD and Brian Schoenfeld, MS, LCGC, in our upcoming webinar as they provide an overview of the importance of genomic testing for patients with potential rare disease and introduce you to the new Zenith™ platform from #Natera.
Register today: https://ow.ly/JOZl50YuWNB
Two new publications highlight the clinical utility of Signatera™ in anal and rectal cancers. By providing earlier insight into molecular residual disease, Signatera can support more individualized surveillance and treatment decisions. https://ow.ly/zVCZ50YuTC5
#ctDNA #Natera
Register today for our upcoming webinar with Fenting Yan, MD, PhD and Jamie McKenzie, MD highlighting three of the twelve studies presented at the San Antonio Breast Cancer Symposium (SABCS).
Reserve your spot: https://ow.ly/tLe450YtAIR
#Natera #ctDNA
MyOme Unveils Zenith™ Diagnostics at ACMG 2026 with Natera's Partnership #United_States #Menlo_Park #Natera #MyOme #Zenith
Don’t miss our upcoming event, Shaping the future of skin cancer: Tumor-informed ctDNA-guided intervention.
Register here: https://ow.ly/tPbL50YrR6N
#ctDNA #Natera
Here’s a snapshot from last week, when #Natera was recognized as Healthcare Technology Company of the Year!
Oded Wohl, our Vice President of Product Development and Engineering, accepted on behalf of our team and spoke about our mission. Thank you to Healthcare Technology Report for this honor.
Colorectal cancer remains one of the most common cancers worldwide. Wearing blue is one way to show support, start conversations and encourage screening. Together, we can help increase awareness and promote access to the tools that make early detection possible. 💙
#DressInBlueDay #CRCMonth #Natera
Amanda was diagnosed with stage IV CRC at 36 while pregnant. Now in survivorship, she uses Signatera™ for post-op surveillance to help manage recurrence risk. With CRC rising in people under 50, earlier detection and informed care matter more than ever. https://ow.ly/hmhE50Ypeuw
#Natera #CRCMonth
This is an important day for Natera with the announcement of new evidence that will be shared on Signatera™ at ASCO GU. Signatera will be featured across 11 scientific abstracts, including 4 oral presentations.
https://ow.ly/2L1E50Yn1O7
American Society of Clinical Oncology #GU26 #Natera
Findings from RenaCARE, evaluating management of CKD one year after RenasightTM testing have been published in @asnpublications.bsky.social.
Results show how genetic insights informed diagnosis, prognosis and family care decisions.
https://ow.ly/cuze50XFUAH
#CKD #Natera #Renasight
Natera Acquires Foresight Diagnostics
oncodaily.com/voices/fores...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Natera #ForesightDiagnostics
We're looking forward to the ASH Annual Meeting this week. View the list of our presentations below and learn more here: https://ow.ly/bbIS50XBvGV
#ASH25 #Natera
Kyle’s experience with stage IV colon cancer underscores the role of early detection and personalized care. With the help of Signatera™ MRD testing, Kyle’s care team identified recurrence before imaging could and took swift action.
See his full story: https://ow.ly/czIF50XAbPg
#MRDtesting #Natera
Across roles and teams at Natera, our genetic counselors help make complex science understandable and personal. They support patients, providers and colleagues alike. Their insights drive innovation and make a difference in every strand of what we do. 🧬 Thank you to our Genetic Counselors! #Natera
👋 #KidneyWk, stop by booth 725 to meet our team, discuss genetics and recharge with some coffee!
ow.ly/Jsht50Xokx9 #Natera
Anj's family history of breast cancer led her to early mammogram screenings and her diagnosis. Today, she's using Signatera™ with her care team to monitor for recurrence.
Watch her full story here: ow.ly/cpfR50Xojqr
#Natera
Safe travels to everyone attending #KidneyWk! See you soon at booth 725.
www.natera.com/organ-health/ #Natera
Naterans assembled Kynd Kits through Project Helping to benefit @firstdescents.bsky.social, a non-profit that provides life-changing outdoor adventures for young adults impacted by cancer and other serious health conditions. 💙💚 #TeamNatera #Natera
The #ISHLTv Industry Webinar from #Natera is next week!
⏰ 6 November | 1:00 p.m. ET
🫀 Gain first-hand insights into #ddcfDNA testing + improved outcomes
💸 Free + open to all!
➡️ Sign up at 🔗 https://bit.ly/46Xep7w
See you soon for #KidneyWk! Stop by booth # 725 to speak to our team. See below for details on the ways we're supporting genetics in the field of nephrology.
@asnkidney.bsky.social
#Natera
Join us at #NSGC25 for our presentations, events and highly anticipated resume review! Learn more in the flyer below and be sure to stop by booth #517 to speak with our team.
#Natera #GeneticCounselors #GeneticCounseling #GC
Proud to support the 4th Annual Gathering of the Wolves, hosted by Man Up To Cancer, an organization dedicated to supporting men with any kind of cancer diagnosis, providing community and resources to guide them through treatment and beyond. #Natera #ManUpToCancer
Man Up to Cancer
Natera is honored to be a national sponsor of the Susan G. Komen More Than Pink Walk series. Together, we walk for hope, progress and a future without breast cancer. Thank you, Susan G. Komen, for welcoming us into this incredible community. 💗 #MoreThanPink #Natera
Susan G. Komen
Natera has been named to @fastcompany.com’s 2025 Next Big Things in Tech list for Signatera™, our personalized MRD test that’s redefining how cancer is detected and managed. ow.ly/wFg050XblTy
#FCTechAwards #Natera
We’re pleased to share a pivotal moment in MRD testing for Signatera™, with the New England Journal of Medicine publishing the results of IMvigor011. www.nejm.org/doi/full/10....
#ESMO25 #Natera
Natera’s technology will be featured across multiple presentations at #ESMO2025. See the full schedule below and stop by booth #1016 to learn more. #Natera #MRD #Signatera
@myesmo.bsky.social
Join #Natera on for a one-hour webinar highlighting how the innovations of #ddcfDNA + #DQS improve detection of rejection, reduce reliance on invasive biopsies, & pave the way for more personalized patient management. #HeartTx 🫀📆
Free to register. Learn more at 🔗 https://bit.ly/46Xep7w
Two smiling women wearing pink vests and bandanas stand behind a Natera-branded booth at an outdoor event. The table is covered with a white cloth featuring the Natera logo and displays pink giveaways, brochures, and framed QR codes. A Natera banner stands behind them, and the booth is set up under a green canopy with trees in the background.
Join us as we celebrate survivors, thrivers & their families at the #SusanGKomen More Than Pink Walk series! #Natera is grateful and honored to be a part of the community.
💗 Miami, FL - 10/4
💗 San Francisco, CA - 10/5
💗 Oxand Hill, MD - 10/11
💗 Austin, TX - 10/26
💗 Los Angeles, CA -10/26
